HIGHLIGHTS
- who: from the (UNIVERSITY) have published the research: AGING, in the Journal: (JOURNAL)
- future: Despite some evidence suggesting that atypical clinical variants of AD largely have tau distributions compatible with the Braak staging system future work is needed before using biomarker-based staging for atypical AD in clinical trials .
SUMMARY
15, No 1 Editorial Applications of Alzheimer`s disease staging to clinical trials Joseph Therriault, Serge Gauthier, Pedro Rosa-Neto Tau-PET may also be useful for monitoring disease modification as a secondary outcome in pivotal randomized controlled trials. While it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.